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Abbreviations used in this table:FL:follicular lymphoma,MCL:mantle cell lymphoma,AIL: 
angioimmunoblastic lymphoma,AML:acute mycloid leukemia,ALL:acute lymphoblastic leukemia, 
FD:fludarabine, dexamethasone, FND:fludarabine,mitoxantrone,dexamethasone,FLAG-M:fludarabine, 
Ara-C,G-CSF,mitoxantronic.FLAG-Ida:fludarabine,Ara-C,G-CSF.idarubicine
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